Application of neuroendoscopic surgical techniques in the assessment and treatment of cerebral ventricular infection

Cerebral ventricular infection(CVI) is one of the most dangerous complications in neurosurgery because of its high mortality and disability rates. Few studies have examined the application of neuroendoscopic surgical techniques(NESTs) to assess and treat CVI. This multicenter, retrospective study was conducted using clinical data of 32 patients with CVI who were assessed and treated by NESTs in China. The patients included 20 men and 12 women with a mean age of 42.97 years. NESTs were used to obliterate intraventricular debris and pus, fenestrate or incise the intraventricular compartment and reconstruct cerebrospinal fluid circulation, and remove artificial material. Intraventricular irrigation with antibiotic saline was applied after neuroendoscopic surgery(NES). Secondary hydrocephalus was treated by endoscopic third ventriculostomy or a ventriculoperitoneal shunt. Neuroendoscopic findings of CVI were used to classify patients into Grade I(n = 3), Grade II(n = 13), Grade III(n = 10), and Grade IV(n = 6) CVI. The three patients with grade I CVI underwent one NES,the 23 patients with grade II/III CVI underwent two NESs, and patients with grade IV CVI underwent two(n = 3) or three(n = 3) NESs.The imaging features and grades of neuroendoscopy results were positively related to the number of neurosurgical endoscopic procedures.Two patients died of multiple organ failure and the other 30 patients fully recovered. Among the 26 patients with secondary hydrocephalus,18 received ventriculoperitoneal shunt and 8 underwent endoscopic third ventriculostomy. There were no recurrences of CVI during the 6-to 76-month follow-up after NES. Application of NESTs is an innovative method to assess and treat CVI, and its neuroendoscopic classification provides an objective, comprehensive assessment of CVI. The study trial was approved by the Institutional Review Board of Beijing Shijitan Hospital, Capital Medical University, China.     

关节镜引导下复位内固定治疗胫骨平台骨折的疗效和对患者膝关节功能恢复及生活质量的影响

目的研究关节镜引导下复位内固定对胫骨平台骨折(FTP)患者的疗效和膝关节功能恢复及生活质量的影响。方法选取该院2016年8月-2018年3月收治的FTP患者104例,采用随机数字法将其分为观察组和对照组,每组52例。观察组行膝关节镜辅助切开复位内固定术,对照组患者行传统切开复位内固定术。比较两组患者的手术指标(切口长度、出血量、手术用时、术后引流量及下床时间)、骨生化指标[Ca~(2+)、降钙素(CT)、骨形态发生蛋白(BMP)和骨特异性碱性磷酸酶(NBAP)]、治疗疗效、膝关节功能Lysholm评分、生活质量SF-36评分和并发症发生情况。结果治疗前,两组患者骨生化指标、膝关节功能Lysholm评分、生活质量SF-36评分均无明显差异(P0.05)。治疗后,观察组切口长度、出血量、术后引流量、下床时间、NBAP明显少于对照组(P 0.01),观察组手术时间、Ca~(2+)、CT、BMP水平、Lysholm评分和SF-36评分均明显高于对照组(P 0.01)。观察组治疗有效率为90.38%,明显高于对照组80.77%(P 0.01)。观察组并发症发生率为11.54%,明显低于对照组28.84%(χ~2=4.69,P=0.002)。结论关节镜引导下复位内固定能够明显提升FTP患者的疗效,促进膝关节功能恢复,改善患者骨代谢指标,提高患者的生活质量,值得向临床推广应用。     

ZBTB16: A new biomarker for primitive neuroectodermal tumor element / Ewing sarcoma

Primitive neuroectodermal tumor (PNET) traditionally encompasses two different classes of tumors with similar morphology - PNET of the peripheral nervous system (pPNET) and PNET of the central nervous system (cPNET). The latter also includes germ cell tumor-derived PNET (gPNET). There are currently no specific markers for gPNET. This study seeks to investigate the expression of ZBTB16 in PNET and other small round blue cell tumors as well as its potential diagnostic utility. Immunohistochemical expression of the ZBTB16 was studied in a total of 27 PNETs (12 pPNETs, 8 cPNETs, 3 primary testicular gPNETs, and 4 metastatic gPNETs) and 38 small round blue cell tumors. Positive expression for ZBTB16 was seen diffusely in 9/12 (75%), moderately in 2/12 (17%) and focally in 1/12 (8%) of pPNETs, diffusely in 3/7 (43%) and moderately in 4/7 (57%) of gPNETs, and diffusely in 2/8 (25%), moderately in 2/8 (25%) and focally in 4/8 (50%) of cPNETs. Whereas, all of the 38 non-PNET small round blue cell tumors were nonreactive. The results suggest that ZBTB16 is a highly sensitive and specific biomarker for both pPNET and gPNET/cPNET. ZBTB16 effectively differentiates PNETs from other small round blue cell tumor mimics, including the two most common germ cell tumor-derived somatic malignancies - rhabdomyosarcoma and nephroblastoma. Of note, compared to the expression of ZBTB16 in pPNET/Ewing sarcoma and gPNET, the expression of ZBTB16 in cPNET was more variable, which appears consistent with the heterogeneity of cPNET. The close proximity of ZBTB16 and FLI-1 genes on chromosome 11q may explain the overexpression of ZBTB16 in PNET, especially in pPNET with t(1122) translocation.